BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7518018)

  • 1. Primary thymic carcinoma: a clinicopathological and immunohistochemical study.
    Shimizu J; Hayashi Y; Morita K; Arano Y; Yoshida M; Oda M; Murakami S; Watanabe Y; Nonomura A
    J Surg Oncol; 1994 Jul; 56(3):159-64. PubMed ID: 7518018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratins in normal thymus and thymic epithelial tumors.
    Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O
    Cancer; 1993 Jan; 71(1):99-105. PubMed ID: 7677978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic carcinoma. A clinicopathologic study of 13 cases.
    Truong LD; Mody DR; Cagle PT; Jackson-York GL; Schwartz MR; Wheeler TM
    Am J Surg Pathol; 1990 Feb; 14(2):151-66. PubMed ID: 1689123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnosis of thymic carcinoma and lung carcinoma with the use of antibodies to cytokeratins.
    Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Niwa H; Kiriyama M; Eimoto T
    J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1670-5. PubMed ID: 8523878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistological analysis of thymoma by molecules differentially expressed in the thymic cortex and medulla, and its application in the differential diagnosis of thymoma from esophageal and lung cancer.
    Shiraishi J; Utsuyama M; Akashi T; Nemoto T; Ohashi K; Akamatsu H; Sunamori M; Kitagawa M; Hirokawa K
    Pathol Res Pract; 2001; 197(9):611-9. PubMed ID: 11569925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas.
    Su XY; Wang WY; Li JN; Liao DY; Wu WL; Li GD
    Int J Clin Exp Pathol; 2015; 8(5):5354-62. PubMed ID: 26191237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunohistochemical study of thymic epithelial tumors. I. Epithelial component.
    Kodama T; Watanabe S; Sato Y; Shimosato Y; Miyazawa N
    Am J Surg Pathol; 1986 Jan; 10(1):26-33. PubMed ID: 2420219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic analysis of 52 cases of thymic epithelial tumor].
    Ma YQ; Miao N; Abulajiang G; Li QX; Liu X; Zhang W; Wang CF; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):249-54. PubMed ID: 20654124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thymomas and thymic carcinomas].
    De Montpréville VT
    Rev Mal Respir; 2010 Dec; 27(10):1281-7. PubMed ID: 21163404
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathology of thymic tumors.
    Hasserjian RP; Ströbel P; Marx A
    Semin Thorac Cardiovasc Surg; 2005; 17(1):2-11. PubMed ID: 16104355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long survival and recurrence of thymic carcinoma 10 years after resection.
    Yabuki H; Minowa M
    Asian Cardiovasc Thorac Ann; 2019 Jun; 27(5):407-409. PubMed ID: 31064197
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary thymic adenocarcinomas: a clinicopathological and immunohistochemical study of 16 cases with emphasis on the morphological spectrum of differentiation.
    Kalhor N; Moran CA
    Hum Pathol; 2018 Apr; 74():73-82. PubMed ID: 29339175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymoma with loss of keratin expression (and giant cells): a potential diagnostic pitfall.
    Adam P; Hakroush S; Hofmann I; Reidenbach S; Marx A; Ströbel P
    Virchows Arch; 2014 Sep; 465(3):313-20. PubMed ID: 24923897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Eight cases of thymic carcinoma].
    Ito H; Obara T; Sasano S; Onuki T; Nitta S
    Nihon Kyobu Geka Gakkai Zasshi; 1994 Nov; 42(11):2060-7. PubMed ID: 7836817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small cell carcinoma of the urinary bladder. A clinicopathological study of six cases.
    Lopez JI; Angulo JC; Flores N; Toledo JD
    Br J Urol; 1994 Jan; 73(1):43-9. PubMed ID: 7507782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of six thymic carcinomas including long-term survivors].
    Tanaka A; Yamauchi A; Ohsawa H; Koyanagi T; Sato T; Sakata J; Maekawa K; Watanabe N; Obama T; Sato H
    Kyobu Geka; 1999 May; 52(5):347-54. PubMed ID: 10319619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas.
    Roden AC; Yi ES; Jenkins SM; Donovan JL; Cassivi SD; Garces YI; Marks RS; Aubry MC
    Hum Pathol; 2015 Jan; 46(1):17-25. PubMed ID: 25455993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymoma. Histologic subclassification is an independent prognostic factor.
    Quintanilla-Martinez L; Wilkins EW; Choi N; Efird J; Hug E; Harris NL
    Cancer; 1994 Jul; 74(2):606-17. PubMed ID: 8033040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunohistochemical study of thymic epithelial tumors. II. Lymphoid component.
    Sato Y; Watanabe S; Mukai K; Kodama T; Upton MP; Goto M; Shimosato Y
    Am J Surg Pathol; 1986 Dec; 10(12):862-70. PubMed ID: 3789252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small cell neuroendocrine carcinoma of the thymus complicated by Cushing's syndrome. Report of a 58-year-old woman with a 3-year history of hypertension.
    Hekimgil M; Hamulu F; Cagirici U; Karabulut B; Ozgen AG; Soydan S; Yilmaz C
    Pathol Res Pract; 2001; 197(2):129-33. PubMed ID: 11261817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.